MI HR0291

Designates July 22, 2020 as Glioblastoma Awareness Day in Michigan to increase public awareness and education about the disease.

Recognizes glioblastoma as the most common and aggressive type of brain tumor, accounting for 48 percent of all primary malignant brain tumors with an estimated 400 new diagnoses in Michigan in 2020.

Notes the severe prognosis: 5-year survival rate of only 6.8 percent and average survival of 12-18 months, with per-patient care costs approaching $150,000 annually.

Acknowledges Michigan's status as a leading center for brain tumor treatment and research, citing facilities such as the Hermelin Brain Tumor Center at Henry Ford Hospital and Rogel Cancer Center at University of Michigan.

Calls for increased research into diagnosis, screening, and treatments for brain tumors, and expresses support for patients, families, caregivers, and collaborative research efforts.